CLINICAL TRIALS PROFILE FOR LEQVIO
✉ Email this page to a colleague
All Clinical Trials for leqvio
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05004675 ↗ | Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients | Not yet recruiting | Medpace, Inc. | Phase 3 | 2021-10-15 | Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisiran (Leqvio®) 284 in patients at very-high risk or high-risk for CVD on stable diet and oral LDL-C-lowering drug therapy |
NCT05004675 ↗ | Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients | Not yet recruiting | LIB Therapeutics LLC | Phase 3 | 2021-10-15 | Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisiran (Leqvio®) 284 in patients at very-high risk or high-risk for CVD on stable diet and oral LDL-C-lowering drug therapy |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for leqvio
Condition Name
Clinical Trial Progress for leqvio
Clinical Trial Phase
Clinical Trial Sponsors for leqvio
Sponsor Name